Axa’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
231,978
+370
| +0.2% | +$3.01K | 0.01% | 781 |
|
|
2025
Q1 | $1.82M | Sell |
231,608
-294
| -0.1% | -$2.31K | 0.01% | 754 |
|
|
2024
Q4 | $3.45M | Sell |
231,902
-364
| -0.2% | -$5.42K | 0.01% | 642 |
|
|
2024
Q3 | $3.55M | Buy |
232,266
+66
| +0% | +$1.01K | 0.01% | 632 |
|
|
2024
Q2 | $3.54M | Buy |
232,200
+128
| +0.1% | +$1.95K | 0.01% | 624 |
|
|
2024
Q1 | $4.38M | Buy |
232,072
+63
| +0% | +$1.19K | 0.01% | 587 |
|
|
2023
Q4 | $4.43M | Sell |
232,009
-5,610
| -2% | -$107K | 0.01% | 576 |
|
|
2023
Q3 | $4.27M | Buy |
237,619
+89,450
| +60% | +$1.61M | 0.02% | 564 |
|
|
2023
Q2 | $3.01M | Buy |
148,169
+2,038
| +1% | +$41.4K | 0.01% | 651 |
|
|
2023
Q1 | $2.67M | Sell |
146,131
-320
| -0.2% | -$5.84K | 0.01% | 704 |
|
|
2022
Q4 | $3.03M | Sell |
146,451
-885
| -0.6% | -$18.3K | 0.01% | 704 |
|
|
2022
Q3 | $3.85M | Sell |
147,336
-44,074
| -23% | -$1.15M | 0.02% | 634 |
|
|
2022
Q2 | $4.85M | Buy |
191,410
+56,895
| +42% | +$1.44M | 0.02% | 589 |
|
|
2022
Q1 | $4.25M | Hold |
134,515
| – | – | 0.01% | 691 |
|
|
2021
Q4 | $5.44M | Buy |
+134,515
| New | +$5.44M | 0.01% | 644 |
|